Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

<p>Abstract</p> <p>Background</p> <p>Access to medicines in developing countries continues to be a significant problem due to lack of insurance and lack of affordability. Chronic Myeloid Leukemia (CML), a rare disease, can be treated effectively, but the pharmaceutical...

Full description

Bibliographic Details
Main Authors: Vandoros Sotiris, Kanavos Panos, Garcia-Gonzalez Pat
Format: Article
Language:English
Published: BMC 2009-12-01
Series:Globalization and Health
Online Access:http://www.globalizationandhealth.com/content/5/1/19